Bioforce Nanosciences Holdings (BFNH) Debt Ratio (2020 - 2022)

Bioforce Nanosciences Holdings has disclosed Debt Ratio across 3 years of filings, most recently posting 219.57 for Q3 2022.

• Quarterly Debt Ratio rose 4773.6% year-over-year to 219.57 in Q3 2022, while the trailing twelve-month figure through Sep 2022 was 219.57 (up 4773.6% YoY) and the FY2021 annual result came in at 10.42, up 518.71% from the prior year.
• Debt Ratio rose to 219.57 in Q3 2022, from 17.0 in the prior quarter.
• Over five years, Debt Ratio peaked at 219.57 in Q3 2022 and troughed at 1.68 in Q4 2020.
• A 3-year average of 38.68 and a median of 10.42 in 2021 frame the typical range for Debt Ratio.
• Biggest YoY gain for Debt Ratio was 4773.6% in 2022; the steepest drop was 306.22% in 2022.
• Tracing BFNH's Debt Ratio over 3 years: stood at 1.68 in 2020, then surged by 518.71% to 10.42 in 2021, then surged by 2006.39% to 219.57 in 2022.
• Business Quant data shows BFNH's Debt Ratio at 219.57 in Q3 2022, 17.0 in Q2 2022, and 13.42 in Q1 2022.